What Researchers Did
Researchers compared two groups of patients with bisphosphonate-related osteonecrosis of the jaw: one got hyperbaric oxygen added to surgery and antibiotics, and the other got surgery and antibiotics alone.
What They Found
In this randomized controlled trial of 46 patients with bisphosphonate-related osteonecrosis of the jaw, 17 of 25 patients given hyperbaric oxygen (68%) improved versus 8 of 21 controls (38.1%), with a p-value of 0.043. The oxygen was given at 2 atm twice a day for 40 treatments, and patients were followed for 24 months. Mean time to improvement was 39.7 weeks with hyperbaric oxygen versus 67.9 weeks for controls (p-value 0.03). Complete gum healing did not differ significantly: 14 of 25 (52%) versus 7 of 21 (33.3%), with a p-value of 0.203. Time to healing was also not significantly different (p-value 0.32). Pain decreased faster in the hyperbaric oxygen group, and physical health and perceived health quality-of-life scores fell at 6 months in the control group but not in the hyperbaric oxygen group.
What This Means for Canadian Patients
For people with jaw osteonecrosis linked to bisphosphonate drugs, this trial found more patients improved and pain eased faster when hyperbaric oxygen was added to surgery and antibiotics. It did not find a significant difference in complete gum healing. The authors say hyperbaric oxygen appears to be a useful add-on, but that the study was underpowered to fully support this.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The authors state the study was underpowered to fully support its conclusion, and the differences in complete gum healing and time to healing were not statistically significant.